Surpreet Chopra Life Sciences Private Limited
About Surpreet Chopra Life Sciences Private Limited
Data last updated:
Surpreet Chopra Life Sciences Private Limited is a private limited company based in Durg, Chhattisgarh, India. It operates in the hospital services segment of the healthcare sector. It was incorporated on 15 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U85110CT2015PTC001778. Its GSTIN is 22AAWCS0815J1Z6 (Chhattisgarh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Surpreet Chopra and Rahul Gulati.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 134 Shanker Nagar, Durg, Chhattisgarh, India – 491001.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.7 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹84,608 (net margin 3.9%) and EBITDA of ₹1.88 Lakh (EBITDA margin 8.7%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 8% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Surpreet Chopra Life Sciences Private Limited's registered office is in Durg, Chhattisgarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No. 134 Shanker Nagar, Durg, Chhattisgarh, India – 491001
- IndustryHealthcare, Hospital Services
To see the full contact details of Surpreet Chopra Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Surpreet Chopra Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Surpreet Chopra Life Sciences Private Limited, buy the company report.
Financials of Surpreet Chopra Life Sciences Private Limited
FY 2025 filings availableSurpreet Chopra Life Sciences Private Limited reported revenue of ₹21.7 Lakh (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 15% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA fell 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.88 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹84,608 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.7% | ||||
| Net Profit Margin | 3.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Surpreet Chopra Life Sciences Private Limited, buy the company report.
Board of directors of Surpreet Chopra Life Sciences Private Limited
Surpreet Chopra Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surpreet Chopra | Director | 15 Jun 2015 | 11 Years 5 Months | Current |
| Rahul Gulati | Director | 15 Jun 2015 | 11 Years 5 Months | Current |
Peer comparison
Surpreet Chopra Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jatalia Global Ventures Limited | ₹21.71 Lakh (FY 2023) | 395.0% | Delhi, India | |||
| Samvardhan Agro Market Producer Company Limited | ₹21.71 Lakh (FY 2025) | 136.0% | Hanumangarh, Rajasthan, India | |||
| Gurudev Pharmaceuticals (OPC) Private Limited | ₹21.71 Lakh (FY 2025) | 22.0% | Kalyan, Maharashtra, India | |||
| SS Dial Private Limited | ₹21.71 Lakh (FY 2025) | -89.0% | Delhi, India | |||
| B D R Products (India) Private Limited | ₹21.7 Lakh (FY 2024) | 2.0% | Delhi, India | |||
| Surpreet Chopra Life Sciences Private Limitedthis company | ₹21.7 Lakh (FY 2025) | ₹84,608 | 3.9% | -15.0% | Durg, Chhattisgarh, India | |
| Neoindus Pharma Private Limited | ₹21.7 Lakh (FY 2025) | -47.0% | Bangalore, Karnataka, India | |||
| Saptapadi Agro Farmers Producer Company Limited | ₹21.7 Lakh (FY 2024) | -86.0% | Satana, Maharashtra, India | |||
| Dogo Industries Private Limited | ₹21.69 Lakh (FY 2025) | 94.0% | Nanidaman, Daman and Diu, India | |||
| Amrico Overseas Private Limited | ₹21.69 Lakh (FY 2023) | Howrah, West Bengal, India | ||||
| Aeran Metalics Pvt Ltd | ₹21.69 Lakh (FY 2025) | -24.0% | Howrah, West Bengal, India |
To see the full peer comparison of Surpreet Chopra Life Sciences Private Limited, buy the company report.
Auditor
Surpreet Chopra Life Sciences Private Limited is audited by HARSH JAIN & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARSH JAIN & ASSOCIATES | FY 2017 | 007639C |
Shareholding
The shareholding of Surpreet Chopra Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Surpreet Chopra Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Surpreet Chopra Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Surpreet Chopra Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Surpreet Chopra Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AAWCS0815J1Z6 | Chhattisgarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Surpreet Chopra Life Sciences Private Limited, buy the company report.
Recent activity
Surpreet Chopra Life Sciences Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Rahul Gulati was appointed as Director on 15 Jun 2015.
Frequently asked questions
Surpreet Chopra Life Sciences is an active private limited company based in Durg, Chhattisgarh, India. The company works in hospital services, within the healthcare industry. It was incorporated on 15 June 2015 (11+ years old) and is registered under CIN U85110CT2015PTC001778.
Surpreet Chopra Life Sciences has 2 current directors:
- Surpreet Chopra - Director
- Rahul Gulati - Director
The latest financial statements of Surpreet Chopra Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Surpreet Chopra Life Sciences is 22AAWCS0815J1Z6, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Surpreet Chopra Life Sciences is U85110CT2015PTC001778. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Surpreet Chopra Life Sciences was incorporated on 15 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
The peers of Surpreet Chopra Life Sciences by revenue are Jatalia Global Ventures Limited, Samvardhan Agro Market Producer Company Limited, Gurudev Pharmaceuticals (OPC) Private Limited, SS Dial Private Limited, B D R Products (India) Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Rahul Gulati was appointed as Director on 15 Jun 2015. Surpreet Chopra was appointed as Director on 15 Jun 2015.
The registered office of Surpreet Chopra Life Sciences is at H.No. 134 Shanker Nagar, Durg, Chhattisgarh, India – 491001.
Surpreet Chopra Life Sciences operates in the healthcare industry, in the hospital services segment.
The compliance status of Surpreet Chopra Life Sciences is compliant as of 17 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
